Skip to content

Validation of the ADAMO Watch for the Early Detection of Fall Events in Older Patients

Validazione Dell'Orologio ADAMO Per l'Individuazione Precoce Delle Cadute Nel Paziente Anziano

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04398615
Acronym
ADAMO
Enrollment
100
Registered
2020-05-21
Start date
2020-05-25
Completion date
2020-12-31
Last updated
2020-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Accidental Falls, Wearable Electronic Devices

Keywords

Aged, Telemetry, Wearable Electronic Devices, Fall detection

Brief summary

La Casa nel Parco (CANP) Project is a multidisciplinary project funded by the European Union and Regione Piemonte aimed to explore innovative technology application in the care of older subjects. In this context, ADAMO is a single arm open label trial evaluating the capability of a wearable watch device to correctly detect fall events in community-dwelling older subjects aged 75 years and older, at high risk of falls. Secondary objectives of the study are to identify specific patterns on telemetric measures and health status variations able to predict future fall events, and to evaluate the tolerability and the influence on patient's quality of life of this wearable device. The main objectives of the study are to evaluate the impact of the intervention on 1) medication adherence after discharge 2) medication appropriateness.

Interventions

DEVICEWearable watch device

Every study participant will be given a wearable watch device at the beginning of the study and will be instructed on how to use the device and to wear it continuously throughout the duration of the study (6 months total follow-up). The device will register biometric data and automatically archived. During the follow-up period both healthcare personnel and investigators will not be aware of data (including fall events) registered by the experimental device.

Sponsors

Caretek S.r.l. Turin, Italy
CollaboratorUNKNOWN
Consoft Sistemi S.p.A. Turin, Italy
CollaboratorUNKNOWN
A.O.U. Città della Salute e della Scienza
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Masking description

During the follow-up period both healthcare personnel and investigators will not be aware of data (including fall events) registered by the experimental device.

Eligibility

Sex/Gender
ALL
Age
75 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Aged 75 years and older * At least 2 fall events during the 12 months previous to enrollment * Signed written informed consent

Exclusion criteria

* Severe cognitive impairment * Bedridden condition * Patients unable to walk autonomously (walking aids allowed)

Design outcomes

Primary

MeasureTime frameDescription
Incidence of self-reported fall events6 monthsFall event incidence evaluated through scheduled phone call interviews with the patient or the caregiver, from enrollment every 15 days through to 6 months, recording also timing and context of event, environmental factors, health status at the moment of the event, health consequences, therapeutic modifications.
Incidence of device-reported fall events6 monthsFall event incidence automatically evaluated by the wearable watch device, based on biometric data continuously recorded from enrollment through to 6 months.

Secondary

MeasureTime frameDescription
Variation in quality of life reported at three levels EQ-5D (EQ-5D-5L) QuestionnaireAt enrollment and at 6 monthsPatient's quality of life will be evaluated both at enrollment and at 6 months through the five levels EQ-5D (EQ-5D-3L) Questionnaire, exploring the five dimensions of mobility, self-care, usual activities, pain/discomfort and anxiety depression (each dimension scored 1-3, with 3 indicating worse problems), and a general measure of perceived health on a Visual Analogue Scale (EQ-VAS), scored 0-100 (with 100 indicating the best perceived health possible)
Variation in fear of falling evaluated with Short Falls Efficacy Scale International (Short FES-I)At enrollment and at 6 monthsPatient's fear of falling be evaluated both at enrollment and at 6 months through the Short Falls Efficacy Scale International (Short FES-I) Status (minimum 7-maximum 28, higher levels indicating most severe concern about falling)

Countries

Italy

Contacts

Primary ContactRenata Marinello, MD, PhD
rmarinello@cittadellasalute.to.it0116334771

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026